Procter & Gamble Stock Forecast for 2022 - 2025 - 2030
Updated on 05/25/2022
Based on the current earnings figures, this year's price targets for Procter & Gamble were recently set by eight distinguished experts, with an average mark of $170.00. If it reached this goal, it would represent a potential upside of approximately 15.15% from the previous closing price in May, 2022. The high end is $185.00, and the low is $124.00. If you are interested in PG stock, you should also look at its competitors.
15.15% Upside
Procter & Gamble Fair Value Forecast for 2022 - 2025 - 2030
Procter & Gamble's Fair Value has seen considerable growth in the last three years, rising from $97.65 to $130.97 – a growth of 34.12%. In the next year, analysts believe that Fair Value will reach an unimpressive $135.37 – an increase of 3.36%. For the next nine years, experts predict that Procter & Gamble's Fair Value will grow at a rate of 65.55%.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts |
|---|---|---|---|---|---|---|---|
| JNJ Stock Forecast | Johnson & Johnson | Outperform |
3
|
$181.40 | $187.12 | 1.98% | 16 |
| ABT Stock Forecast | Abbott Laboratories | Outperform |
7
|
$113.77 | $141.24 | 23.06% | 19 |
| COST Stock Forecast | Costco Wholesale | Outperform |
6
|
$437.71 | $584.00 | 34.11% | 12 |
| GSK Stock Forecast | GlaxoSmithKline | Outperform |
1
|
£17.64 | £16.08 | 2.04% | 11 |
| MO Stock Forecast | Altria Group | Outperform |
9
|
$52.93 | $56.79 | 7.31% | 13 |
Procter & Gamble Revenue Forecast for 2022 - 2025 - 2030
Procter & Gamble's Revenue has seen considerable growth in the last three years, rising from $66.83B to $76.12B – a growth of 13.89%. In the next year, analysts believe that Revenue will reach an unimpressive $80.10B – an increase of 5.23%. For the next nine years, experts predict that Procter & Gamble's Revenue will grow at a rate of 40.22%.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts |
|---|---|---|---|---|---|---|---|
| 500696 Stock Forecast | Hindustan Unilever | Outperform |
6
|
Rp2.31k | Rp2.84k | 9% | 16 |
| BAYN Stock Forecast | Bayer | Outperform |
5
|
63.29€ | 67.79€ | 20.08% | 14 |
| CL Stock Forecast | Colgate-Palmolive | Hold |
5
|
$78.12 | $84.90 | 4.97% | 9 |
Procter & Gamble Dividend per Share Forecast for 2022 - 2025 - 2030
Procter & Gamble's DPS has seen impressive growth in the last three years, rising from $2.79 to $3.24 – a growth of 16.13%. In the next year, analysts believe that DPS will reach an unimpressive $3.50 – an increase of 8.02%. For the next nine years, the forecast is for DPS to grow by 82.1%.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts |
|---|---|---|---|---|---|---|---|
| KER Stock Forecast | Kering | Outperform |
4
|
450.35€ | 796.00€ | 69.31% | 13 |
| ECL Stock Forecast | Ecolab | Outperform |
4
|
$158.40 | $204.59 | 21.84% | 10 |
| KMB Stock Forecast | Kimberly-Clark | Hold |
4
|
$132.15 | $138.11 | -0.11% | 6 |
Procter & Gamble Free Cash Flow Forecast for 2022 - 2025 - 2030
In the last three years, Procter & Gamble's Free Cash Flow has seen relatively significant growth, growing from $11.15B to $15.58B – an increase of 39.77%. In the following year, 10.00 experts forecast Procter & Gamble's Free Cash Flow will decrease by 3.55 percent, to $15.03B. Looking ahead to nine years, experts forecast that Free Cash Flow will grow by 37.47%.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts |
|---|---|---|---|---|---|---|---|
| GIS Stock Forecast | General Mills | Hold |
2
|
$69.14 | $67.53 | -1.65% | 18 |
| BN Stock Forecast | Danone | Hold |
4
|
54.87€ | 62.59€ | 2.06% | 18 |
| HEN3 Stock Forecast | Henkel AG & Co. KGaA | Hold |
5
|
61.78€ | 95.86€ | 10.07% | 17 |
Procter & Gamble Net Income Forecast for 2022 - 2025 - 2030
In the past three years, Procter & Gamble's Net Income has grown by 46.73%, rising from $9.75B to $14.31B. For the next year, analysts predict that Net Income will reach $14.86B – an increase of 3.87%. Over the next nine years, experts believe that PG's Net Income will grow at a rate of 45.56%.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts |
|---|---|---|---|---|---|---|---|
| K Stock Forecast | Kellogg | Hold |
5
|
$70.45 | $71.29 | -0.64% | 18 |
| PHIA Stock Forecast | Koninklijke Philips N.V. | Outperform |
4
|
29.99€ | 50.07€ | 1.7% | 8 |
| BEI Stock Forecast | Beiersdorf | Outperform |
4
|
95.38€ | 102.71€ | 11.13% | 13 |
Procter & Gamble EBITDA Forecast for 2022 - 2025 - 2030
In the past three years, Procter & Gamble's EBITDA has seen a relatively significant increase, rising from $16.20B to $21.53B. This represents a growth of 32.91%. According to 16.00 major analysts, Procter & Gamble's EBITDA will fall by 2.75% in the next year, reaching a lowly $20.94B. Over the next nine years, experts predict that Procter & Gamble's EBITDA will grow at a rate of 39.31%
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts |
|---|---|---|---|---|---|---|---|
| CHD Stock Forecast | Church & Dwight | Hold |
5
|
$90.43 | $88.52 | 9.48% | 9 |
| 4452 Stock Forecast | Kao | Outperform |
2
|
¥6.11k | ¥0.00 | 7.25% | 0 |
| ESSITY B Stock Forecast | Essity AB (publ) | Outperform |
1
|
kr274.50 | kr0.00 | 7.47% | 12 |
Procter & Gamble EBIT Forecast for 2022 - 2025 - 2030
Procter & Gamble's EBIT has seen considerable growth in the last three years, going from $13.36B to $18.79B – a gain of 40.63% In the next year, 15.00 analysts estimate that Procter & Gamble's EBIT will decrease by 4.1%, reaching $18.02B. For the next nine years, the forecast is for EBIT to grow by 39.84%
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts |
|---|---|---|---|---|---|---|---|
| CA Stock Forecast | Carrefour | Outperform |
4
|
19.11€ | 19.32€ | 15.12% | 12 |
| CPB Stock Forecast | Campbell Soup | Hold |
3
|
$47.76 | $45.55 | -3.69% | 2 |
| BIM Stock Forecast | bioMérieux | Outperform |
6
|
91.46€ | 113.60€ | 20.27% | 4 |
Procter & Gamble EPS Price Prediction Forecast for 2022 - 2025 - 2030
Procter & Gamble's EPS has seen considerable growth in the last three years, rising from $4.22 to $5.66 – a growth of 34.12%. In the next year, analysts believe that EPS will reach an unimpressive $5.85 – an increase of 3.36%. For the next nine years, experts predict that Procter & Gamble's EPS will grow at a rate of 65.55%.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts |
|---|---|---|---|---|---|---|---|
| BBWI Stock Forecast | Bath & Body Works | Buy |
4
|
$36.15 | $68.79 | 77.04% | 0 |
| 500124 Stock Forecast | Dr. Reddy's Laboratories | Outperform |
4
|
Rp4.32k | Rp5.47k | 14.56% | 12 |
| A090430 Stock Forecast | Amorepacific | Outperform |
2
|
₩150.50k | ₩269.69k | 39.2% | 16 |